HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

NCT04564872 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

465

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: HSK7653 10 mg Q2W
DRUG: HSK7653 25 mg Q2W
DRUG: Linagliptin 5 mg QD

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd